Vancomycin-resistant enterococcal bacteremia:: comparison of clinical features and outcome between Enterococcus faecium and Enterococcus faecalis

被引:0
|
作者
Chou, Yen-Yi [1 ]
Lin, Te-Yu [1 ]
Lin, Jung-Chung [1 ]
Wang, Ning-Chi [1 ]
Peng, Ming-Yieh [1 ]
Chang, Feng-Yee [1 ]
机构
[1] Natl Def Med Ctr, Tri Serv Gen Hosp, Dept Med, Div Infect Dis & Trop Med, Taipei 114, Taiwan
关键词
bacteremia; Enterococcus faecalis; Enterococcus faecium; vancomycin resistance;
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background and Purpose: Vancomycin-resistant enterococci (VRE) have emerged as important nosocomial pathogens. This study was conducted to clarify the clinical features and outcome of patients with vancomycin-resistant enterococcal bacteremia. Methods: Patients with vancomycin-resistant enterococcal bacteremia treated at a medical center in northern Taiwan between November 1998 and July 2006 were reviewed. Clinical and bacteriological characteristics of Enterococcus faecium and Enterococcus faecalis were compared. Results: Twelve patients (6 males and 6 females) were included for analyses. The mean age was 69.3 years (range, 40 to 86 years), and 8 cases (66.7%) were older than 65 years. All patients had underlying disease. Two patients received total hip replacement before development of VRE bacteremia. Twelve patients had prior exposure to broad-spectrum antimicrobial therapy. Ten patients had prior intensive care unit stay and prior mechanical ventilation before VRE bacteremia. All of the patients (n = 12) had an intravascular catheter in place. Bacteremia was caused by E faecalis in 4 patients and by E faecium in eight. The portals of entry included urinary tract (8.3%), skin, soft tissue and bone (41.7%) and unknown sources (50.0%). E faecium showed a higher rate of resistance to ampicillin and teicoplanin than E faecalis (87.5% vs 0.0%, p=0.01). The 60-day mortality rate was higher in patients with E. faecium bacteremia than E faecalis bacteremia (62.5% vs 0.0%), although statistical significance was not obtained (p=0.08). Conclusions: VRE bacteremia may have an impact on the mortality and morbidity of hospitalized patients. Patients with bacteremia caused by vancomycin-resistant E faecium had a grave prognosis, especially immuno-suppressed patients. The prudent use of antibiotics and strict enforcement of infection control may prevent further emergence and spread of VRE.
引用
下载
收藏
页码:124 / 129
页数:6
相关论文
共 50 条
  • [21] Genomics of vancomycin-resistant Enterococcus faecium
    Gorrie, Claire
    Higgs, Charlie
    Carter, Glen
    Stinear, Timothy P.
    Howden, Benjamin
    MICROBIAL GENOMICS, 2019, 5 (07):
  • [22] Vancomycin-resistant Enterococcus faecalis in Serbia
    Stosovic, B
    Stepanovic, S
    Donabedian, S
    Tosic, T
    Jovanovic, M
    EMERGING INFECTIOUS DISEASES, 2004, 10 (01) : 157 - 158
  • [23] β-Lactam combinations with daptomycin provide synergy against vancomycin-resistant Enterococcus faecalis and Enterococcus faecium
    Smith, Jordan R.
    Barber, Katie E.
    Raut, Animesh
    Aboutaleb, Mostafa
    Sakoulas, George
    Rybak, Michael J.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2015, 70 (06) : 1738 - 1743
  • [24] Molecular and clinical epidemiology of vancomycin-resistant Enterococcus faecalis
    Oprea, SF
    Zaidi, N
    Donabedian, SM
    Balasubramaniam, M
    Hershberger, E
    Zervos, MJ
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 53 (04) : 626 - 630
  • [25] Clinical isolation of vancomycin-resistant Enterococcus faecalis in Taiwan
    Ben, RJ
    Lu, JJ
    Young, TG
    Chi, WM
    Wang, CC
    Chu, ML
    Wang, JC
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 1996, 95 (12) : 946 - 949
  • [26] Daptomycin in the treatment of vancomycin-resistant Enterococcus faecium bacteremia in neutropenic patients
    Poutsiaka, Debra D.
    Skiffington, Serena
    Miller, Kenneth B.
    Hadley, Susan
    Snydman, David R.
    JOURNAL OF INFECTION, 2007, 54 (06) : 567 - 571
  • [27] Catheter-related vancomycin-resistant Enterococcus faecium bacteremia:: Clinical and molecular epidemiology
    Raad, II
    Hanna, HA
    Boktour, M
    Jabbour, N
    Hachem, RY
    Darouiche, RO
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2005, 26 (07): : 658 - 661
  • [28] Clinical Outcomes of Daptomycin for Vancomycin-resistant Enterococcus Bacteremia
    Moise, Pamela A.
    Sakoulas, George
    McKinnell, James A.
    Lamp, Kenneth C.
    DePestel, Daryl D.
    Yoon, Min J.
    Reyes, Katherine
    Zervos, Marcus J.
    CLINICAL THERAPEUTICS, 2015, 37 (07) : 1443 - 1453
  • [29] Emergence of vancomycin-resistant Enterococcus faecium in Sfax:: clinical features and molecular typing
    Abbassi, M. S.
    Znazen, A.
    Mahjoubi, F.
    Hammami, A.
    Ben Hassen, A.
    MEDECINE ET MALADIES INFECTIEUSES, 2007, 37 (04): : 240 - 241
  • [30] BACTEREMIA CAUSED BY A VANCOMYCIN-RESISTANT ENTEROCOCCUS
    BINGEN, E
    LAMBERTZECHOVSKY, N
    MARIANIKURKDJIAN, P
    CEZARD, JP
    NAVARRO, J
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1989, 8 (07) : 475 - 476